Clever Leaves (CLVR) Competitors $0.0004 0.00 (0.00%) As of 06/6/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock CLVR vs. EFTR, ONCSQ, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, and BFRIWShould you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry. Clever Leaves vs. Its Competitors eFFECTOR Therapeutics OncoSec Medical PaxMedica 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera eFFECTOR Therapeutics (NASDAQ:EFTR) and Clever Leaves (NASDAQ:CLVR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, community ranking, profitability, risk, analyst recommendations, dividends and media sentiment. Which has better valuation & earnings, EFTR or CLVR? Clever Leaves has higher revenue and earnings than eFFECTOR Therapeutics. Clever Leaves is trading at a lower price-to-earnings ratio than eFFECTOR Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeFFECTOR Therapeutics$3.55M0.00-$35.81M-$13.080.00Clever Leaves$17.42M0.00-$17.90M-$11.310.00 Does the media prefer EFTR or CLVR? In the previous week, eFFECTOR Therapeutics' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score. Company Overall Sentiment eFFECTOR Therapeutics Neutral Clever Leaves Neutral Do insiders & institutionals have more ownership in EFTR or CLVR? 57.7% of eFFECTOR Therapeutics shares are held by institutional investors. Comparatively, 6.9% of Clever Leaves shares are held by institutional investors. 4.7% of eFFECTOR Therapeutics shares are held by company insiders. Comparatively, 8.2% of Clever Leaves shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community prefer EFTR or CLVR? eFFECTOR Therapeutics received 10 more outperform votes than Clever Leaves when rated by MarketBeat users. However, 81.25% of users gave Clever Leaves an outperform vote while only 79.31% of users gave eFFECTOR Therapeutics an outperform vote. CompanyUnderperformOutperformeFFECTOR TherapeuticsOutperform Votes2379.31% Underperform Votes620.69% Clever LeavesOutperform Votes1381.25% Underperform Votes318.75% Which has more risk and volatility, EFTR or CLVR? eFFECTOR Therapeutics has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, Clever Leaves has a beta of 3516.09, meaning that its share price is 351,509% more volatile than the S&P 500. Is EFTR or CLVR more profitable? Company Net Margins Return on Equity Return on Assets eFFECTOR TherapeuticsN/A N/A N/A Clever Leaves N/A N/A N/A SummaryClever Leaves beats eFFECTOR Therapeutics on 6 of the 10 factors compared between the two stocks. Get Clever Leaves News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLVR vs. The Competition Export to ExcelMetricClever LeavesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$6.85B$5.57B$8.62BDividend YieldN/A2.55%5.28%4.18%P/E Ratio0.008.7827.1420.06Price / Sales0.00255.49419.32157.08Price / CashN/A65.8538.2534.64Price / Book0.006.557.064.70Net Income-$17.90M$143.93M$3.23B$247.88M7 Day PerformanceN/A3.84%2.83%2.63%1 Month PerformanceN/A11.20%9.02%6.36%1 Year PerformanceN/A4.18%31.36%14.05% Clever Leaves Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVRClever LeavesN/A$0.00flatN/A-100.0%$1K$17.42M0.00560EFTReFFECTOR TherapeuticsN/A$0.00+100.0%N/A-100.0%$1K$3.55M0.0010Gap UpONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040PXMDPaxMedicaN/A$0.00flatN/A-100.0%$1KN/A0.002ATNFW180 Life SciencesN/A$0.01-10.5%N/A-42.3%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01+53.1%N/AN/A$0.00N/A0.002Gap UpAIMDWAinosN/A$0.11-4.1%N/A+67.4%$0.00$106.21K0.0040ALVOWAlvotechN/A$2.58+3.6%N/A-35.8%$0.00$585.60M0.004Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02-16.5%N/AN/A$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.09+0.2%N/A+75.2%$0.00$38.00M0.0070 Related Companies and Tools Related Companies EFTR Alternatives ONCSQ Alternatives PXMD Alternatives ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives BFRIW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLVR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clever Leaves With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLVR Stock Free CLVR Stock Alerts